From the Novartis Ann in March 2010:
" This (collaboration) opens up a whole new source of partnership opportunities for Phosphagenics," says Dr. Ogru. "Working with Novartis in the veterinary sector aligns with our commercialization strategy of diversifying the application of our technology into many and varied fields. We are very pleased to be working with one of the world leaders in animal health."
"opens up a whole new source of partnership opportunities for Phosphagenics".....Ill bet it does Esra. there is your proof Novartis is our lead candidate for a POH Human Insulin TPM Patch deal..and as I posted earlier a Dyclofenac deal as a bonus.
Awesome :)
KC
tpm 02 insulin, page-18
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $2.565K | 874.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 40547400 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39021116 | 27 |
View Market Depth
| Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |